BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30578675)

  • 1. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody.
    Lubetzky M; Hayde N; Ó Broin P; Ajaimy M; Bao Y; Mohammed O; Schwartz D; Pullman J; Akalin E
    Clin Transplant; 2019 Mar; 33(3):e13469. PubMed ID: 30578675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
    Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation.
    Parajuli S; Redfield RR; Garg N; Aziz F; Mohamed M; Astor BC; Zhong W; Djamali A; Mandelbrot DA
    Transplantation; 2019 Jul; 103(7):1468-1476. PubMed ID: 30335696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative approach for the assessment of peritubular capillaritis extent and score in low-grade microvascular inflammation-associations with transplant glomerulopathy and graft loss.
    Kozakowski N; Herkner H; Eskandary F; Eder M; Winnicki W; Kläger J; Bond G; Kikic Ž
    Nephrol Dial Transplant; 2019 Jan; 34(1):166-174. PubMed ID: 30053273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic patterns and treatment of transplant glomerulopathy: A retrospective analysis.
    Abreu R; Carvalho F; Viana H; Mesquita I; Possante M; Aires I; Caeiro F; Silva C; Cotovio P; Ferreira A; Remédio F; Nolasco F
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28135784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
    Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
    Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies.
    Gupta A; Broin PÓ; Bao Y; Pullman J; Kamal L; Ajaimy M; Lubetzky M; Colovai A; Schwartz D; de Boccardo G; Golden A; Akalin E
    Kidney Int; 2016 Jan; 89(1):217-25. PubMed ID: 26422506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Microvascular Inflammation in ABO-Incompatible Kidney Transplantation.
    Ishihara H; Ishida H; Unagami K; Hirai T; Okumi M; Omoto K; Shimizu T; Tanabe K
    Transplantation; 2017 Jun; 101(6):1423-1432. PubMed ID: 27495756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, Histological, and Molecular Markers Associated With Allograft Loss in Transplant Glomerulopathy Patients.
    Kamal L; Broin PÓ; Bao Y; Ajaimy M; Lubetzky M; Gupta A; de Boccardo G; Pullman J; Golden A; Akalin E
    Transplantation; 2015 Sep; 99(9):1912-8. PubMed ID: 25675205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.
    Senev A; Van Loon E; Lerut E; Callemeyn J; Coemans M; Van Sandt V; Kuypers D; Emonds MP; Naesens M
    Kidney Int; 2021 Aug; 100(2):401-414. PubMed ID: 33675843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.
    Callemeyn J; Senev A; Coemans M; Lerut E; Sprangers B; Kuypers D; Koenig A; Thaunat O; Emonds MP; Naesens M
    J Am Soc Nephrol; 2021 Aug; 32(8):2070-2082. PubMed ID: 34301794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up.
    Rabant M; Boullenger F; Gnemmi V; Pellé G; Glowacki F; Hertig A; Brocheriou I; Suberbielle C; Taupin JL; Anglicheau D; Legendre C; Duong Van Huyen JP; Buob D
    Am J Transplant; 2018 Apr; 18(4):972-981. PubMed ID: 29206350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass.
    Cristoferi I; Varol H; van Baardwijk M; Rahiem L; Lila KA; van den Bosch TPP; Baan CC; Hesselink DA; Kramann R; Minnee RC; Mustafa DAM; Reinders MEJ; Roelen DL; Shahzad-Arshad SP; Smith RN; Stubbs AP; Colvin RB; Rosales IA; Clahsen-van Groningen MC
    Kidney Int; 2024 Apr; 105(4):812-823. PubMed ID: 38128610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of C4d and microvascular inflammation before we knew them.
    Verghese P; Dunn T; Najafian B; Kim Y; Matas A
    Clin Transplant; 2013; 27(3):388-96. PubMed ID: 23528049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients.
    Buob D; Grimbert P; Glowacki F; Labalette M; Dufossé F; Nochy D; Copin MC; Boleslawski E; Noël C; Hazzan M
    Transpl Int; 2012 Jun; 25(6):663-70. PubMed ID: 22487459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection.
    Madill-Thomsen KS; Böhmig GA; Bromberg J; Einecke G; Eskandary F; Gupta G; Hidalgo LG; Myslak M; Viklicky O; Perkowska-Ptasinska A; Halloran PF;
    J Am Soc Nephrol; 2021 Nov; 32(11):2743-2758. PubMed ID: 34253587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.
    Aubert O; Higgins S; Bouatou Y; Yoo D; Raynaud M; Viglietti D; Rabant M; Hidalgo L; Glotz D; Legendre C; Delahousse M; Shah N; Sis B; Campbell P; Mengel M; Jouven X; Duong Van Huyen JP; Lefaucheur C; Loupy A
    J Am Soc Nephrol; 2019 Apr; 30(4):625-639. PubMed ID: 30872323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
    Kwon H; Kim YH; Choi JY; Shin S; Jung JH; Park SK; Han DJ
    Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.